Entrada Therapeutics Inc (TRDA)
Cost of Revenue
$40.05M
TTM · Period ending: · USD
TRDA Cost of Revenue
Latest reported$40.05Mperiod ending
Latest reported$40.05Mperiod ending
TRDA TTM Cost of Revenue ($0.00 → $40.05M)
TTM cost of revenue
High-resolution chart · PNG
TRDA cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 40,052,000 | |
| 40,052,000 | |
| 39,247,000 | |
| 38,361,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 22,191,000 | |
| 48,491,000 | |
| 71,593,000 | |
| 71,593,000 | |
| 49,402,000 | |
| 23,102,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |